We are live on
!
Find out more
CM
Caption Management Portfolio holdings
AUM
$17.1B
1-Year Est. Return
70.99%
This Fund
S&P 500
This Quarter
Est. Return
+4.28%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
–
AUM
$1.99B
AUM Growth
+$172M
(+9.5%)
Cap. Flow
+$156M
Cap. Flow
% of AUM
7.83%
Top 10 Holdings %
Top 10 Hldgs %
16.27%
Holding
935
New
395
Increased
92
Reduced
99
Closed
294
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
+$8.42M |
| 2 |
Marathon Petroleum
MPC
|
+$5.47M |
| 3 |
Liberty Global Class C
LBTYK
|
+$5.39M |
| 4 |
O'Reilly Automotive
ORLY
|
+$5.32M |
| 5 |
Crocs
CROX
|
+$5.07M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$12.6M |
| 2 |
Tapestry
TPR
|
+$12M |
| 3 |
iShares MSCI Saudi Arabia ETF
KSA
|
+$8.32M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$6.96M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
+$6.93M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.95% |
| 2 | Consumer Discretionary | 2.51% |
| 3 | Technology | 1.96% |
| 4 | Energy | 1.43% |
| 5 | Communication Services | 1.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Delek US
DK
$4.16B
| $3.24M | 0.16% |
80,000
-22,800
| -22% | -$834K |
|
177
PUT
Ionis Pharmaceuticals
IONS
$8.6B
| $3.23M | 0.16% |
50,300
-54,700
| -52% | -$3.87M |
|
178
CALL
MPLX
MPLX
$59.3B
| $3.22M | 0.16% |
100,000
| – | – |
|
|
179
PUT
MPLX
MPLX
$59.3B
| $3.22M | 0.16% |
100,000
| – | – |
|
180
PUT
Alarm.com
ALRM
$2.71B
| $3.21M | 0.16% |
60,000
| – | – |
|
181
CALL
Turning Point Brands
TPB
$1.45B
| $3.21M | 0.16% |
+65,500
| New | +$3.16M |
|
|
182
PUT
Turning Point Brands
TPB
$1.45B
| $3.21M | 0.16% |
+65,500
| New | +$3.16M |
|
183
PUT
BioMarin Pharmaceuticals
BMRN
$11.6B
| $3.19M | 0.16% |
37,300
+23,800
| +176% | +$2.04M |
|
184
CALL
United Parks & Resorts
PRKS
$2.1B
| $3.1M | 0.16% |
100,000
| – | – |
|
185
CALL
PTC Therapeutics
PTCT
$5.68B
| $3.06M | 0.15% |
68,000
+32,000
| +89% | +$1.26M |
|
186
CALL
Sanofi
SNY
$103B
| $3.03M | 0.15% |
70,000
| – | – |
|
|
MXIM
187
CALL
DELISTED
Maxim Integrated Products
MXIM
| $2.98M | 0.15% |
49,800
| – | – |
|
|
WW
188
CALL
DELISTED
WW International
WW
| $2.96M | 0.15% |
155,000
| – | – |
|
189
Iovance Biotherapeutics
IOVA
$1.82B
| $2.93M | 0.15% |
+119,600
| New | +$1.8M |
|
190
PUT
Northern Oil and Gas
NOG
$2.3B
| $2.93M | 0.15% |
151,850
+62,090
| +69% | +$1.44M |
|
191
HSBC
HSBC
$365B
| $2.92M | 0.15% |
70,000
+39,643
| +131% | +$1.66M |
|
192
CALL
AbbVie
ABBV
$443B
| $2.91M | 0.15% |
40,000
-25,000
| -38% | -$1.96M |
|
193
Laureate Education
LAUR
$5.28B
| $2.9M | 0.15% |
184,500
+73,500
| +66% | +$1.17M |
|
|
SC
194
PUT
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $2.88M | 0.14% |
+120,000
| New | +$2.67M |
|
195
CALL
Stellantis
STLA
$21.7B
| $2.87M | 0.14% |
207,700
-100
| -0% | -$1.45K |
|
196
CALL
Robert Half
RHI
$3.87B
| $2.85M | 0.14% |
+50,000
| New | +$2.98M |
|
|
AABA
197
DELISTED
Altaba Inc
AABA
| $2.84M | 0.14% |
+41,000
| New | +$2.87M |
|
198
Kratos Defense & Security Solutions
KTOS
$8.74B
| $2.75M | 0.14% |
120,000
+60,000
| +100% | +$1.13M |
|
199
PUT
YPF
YPF
$206B
| $2.73M | 0.14% |
150,000
| – | – |
|
|
CTLT
200
PUT
DELISTED
CATALENT, INC.
CTLT
| $2.71M | 0.14% |
+50,000
| New | +$2.29M |
|
Similar funds
ASRS
PP
VMPIC
BCIM
BBA
FCM
AIMCA
Caption Management's Q2 2019 Portfolio in Review
As of Q2 2019, Caption Management held 935 positions worth $1.99B, up 9.5% from $1.81B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Caption Management deployed $156M of net new capital in Q2 2019, opening 395 new positions and adding to 92 existing holdings. Its largest new stake was Spark Therapeutics, Inc. Common Stock: 78,000 shares worth $7.99M.
By sector, the portfolio is most concentrated in Healthcare at 3% of assets, down from 3.9% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $12.6M trimmed.
- Caption Management's largest Q2 2019 buy was Spark Therapeutics, Inc. Common Stock: 78,000 shares worth $7.99M.
- Caption Management added most to Crocs in Q2 2019, an estimated $5.07M increase.
- Caption Management's biggest Q2 2019 reduction was Bristol-Myers Squibb, cutting an estimated $12.6M.
- Caption Management fully exited iShares MSCI Saudi Arabia ETF in Q2 2019, selling an estimated $8.32M.
- Caption Management's ten largest holdings make up 16% of its $1.99B portfolio in Q2 2019.
- Caption Management opened 395 new positions and closed 294 in Q2 2019.
- Caption Management's portfolio value rose 9.5% quarter-over-quarter to $1.99B.
Based on Caption Management's 13F filing for Q2 2019, filed 13 Aug 2019.